Christopher Richard Anzalone, CEO: Arrowhead Pharmaceuticals ARWR Sell · Filed 01/05

Trade details

Type: Insider sale
Amount: $383,136.69
Shares · price: 5,771 sh · $66.39 a share
Held after: 3,792,739 sh
Stock: Arrowhead Pharmaceuticals ARWR
Person: Christopher Richard AnzaloneCEO
Trade date: 26/01/02
Filed: 26/01/05
Days to filing: 3 days

Sold 0.2% of holdings

Share of holding sold: 0.2%

Arrowhead Pharmaceuticals trades, last 26 weeks

What else happened in Arrowhead Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/12/03~02/01

Christopher Richard Anzalone's recent trades

Christopher Richard AnzaloneCEO
Sell10b5-1 planArrowhead Pharmaceuticals
Sell10b5-1 plan
Arrowhead Pharmaceuticals
ARWR
$488.6K
7,416 sh
$488.6K
Filed 01/05
Traded 01/02
Christopher Richard AnzaloneCEO
Planned sale10b5-1 planArrowhead Pharmaceuticals
Planned sale10b5-1 plan
Arrowhead Pharmaceuticals
ARWR
$871.7K
13,187 sh
$871.7K
Filed 01/02
Traded 01/02
Christopher Richard AnzaloneCEO
Sell10b5-1 planArrowhead Pharmaceuticals
Sell10b5-1 plan
Arrowhead Pharmaceuticals
ARWR
$2.4M
35,181 sh
$2.4M
Filed 25/12/30
Traded 25/12/29
Christopher Richard AnzaloneCEO
Sell10b5-1 planArrowhead Pharmaceuticals
Sell10b5-1 plan
Arrowhead Pharmaceuticals
ARWR
$1.1M
16,545 sh
$1.1M
Filed 25/12/30
Traded 25/12/29
Christopher Richard AnzaloneCEO
Planned sale10b5-1 planArrowhead Pharmaceuticals
Planned sale10b5-1 plan
Arrowhead Pharmaceuticals
ARWR
$3.6M
51,726 sh
$3.6M
Filed 25/12/29
Traded 25/12/29

Christopher Richard Anzalone, CEO — sold $383.1K of Arrowhead Pharmaceuticals ARWR · 0.2% of holdings · 10b5-1 plan | Whalegun